| Year |
Citation |
Score |
| 2015 |
Lieberman AP, Iniguez-Lluhi JA. Undoing SUMO aids polyQ AR. Oncotarget. 6: 32283-4. PMID 26431497 DOI: 10.18632/oncotarget.5862 |
0.377 |
|
| 2015 |
McIntyre JC, Joiner AM, Zhang L, Iñiguez-Lluhí J, Martens JR. SUMOylation regulates ciliary localization of olfactory signaling proteins. Journal of Cell Science. 128: 1934-45. PMID 25908845 DOI: 10.1242/Jcs.164673 |
0.38 |
|
| 2014 |
Højfeldt JW, Cruz-Rodríguez O, Imaeda Y, Van Dyke AR, Carolan JP, Mapp AK, Iñiguez-Lluhí JA. Bifunctional ligands allow deliberate extrinsic reprogramming of the glucocorticoid receptor. Molecular Endocrinology (Baltimore, Md.). 28: 249-59. PMID 24422633 DOI: 10.1210/Me.2013-1343 |
0.402 |
|
| 2012 |
Mukherjee S, Cruz-Rodríguez O, Bolton E, Iñiguez-Lluhí JA. The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs. The Journal of Biological Chemistry. 287: 31195-206. PMID 22829593 DOI: 10.1074/Jbc.M112.395210 |
0.348 |
|
| 2012 |
Danciu TE, Chupreta S, Cruz O, Fox JE, Whitman M, Iñiguez-Lluhí JA. Small ubiquitin-like modifier (SUMO) modification mediates function of the inhibitory domains of developmental regulators FOXC1 and FOXC2. The Journal of Biological Chemistry. 287: 18318-29. PMID 22493429 DOI: 10.1074/Jbc.M112.339424 |
0.538 |
|
| 2009 |
Figueroa-Romero C, Iñiguez-Lluhí JA, Stadler J, Chang CR, Arnoult D, Keller PJ, Hong Y, Blackstone C, Feldman EL. SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 3917-27. PMID 19638400 DOI: 10.1096/Fj.09-136630 |
0.387 |
|
| 2009 |
Yang WH, Heaton JH, Brevig H, Mukherjee S, Iñiguez-Lluhí JA, Hammer GD. SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation. Molecular and Cellular Biology. 29: 613-25. PMID 19015234 DOI: 10.1128/Mcb.00295-08 |
0.414 |
|
| 2008 |
Holmstrom SR, Chupreta S, So AY, Iñiguez-Lluhí JA. SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX. Molecular Endocrinology (Baltimore, Md.). 22: 2061-75. PMID 18562626 DOI: 10.1210/Me.2007-0581 |
0.473 |
|
| 2007 |
Chupreta S, Brevig H, Bai L, Merchant JL, Iñiguez-Lluhí JA. Sumoylation-dependent control of homotypic and heterotypic synergy by the Kruppel-type zinc finger protein ZBP-89. The Journal of Biological Chemistry. 282: 36155-66. PMID 17940278 DOI: 10.1074/jbc.M708130200 |
0.596 |
|
| 2007 |
Evelyn CR, Wade SM, Wang Q, Wu M, Iñiguez-Lluhí JA, Merajver SD, Neubig RR. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Molecular Cancer Therapeutics. 6: 2249-60. PMID 17699722 DOI: 10.1158/1535-7163.Mct-06-0782 |
0.383 |
|
| 2003 |
Holmstrom S, Van Antwerp ME, Iñiguez-Lluhi JA. Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy. Proceedings of the National Academy of Sciences of the United States of America. 100: 15758-63. PMID 14663148 DOI: 10.1073/Pnas.2136933100 |
0.474 |
|
| 2002 |
Shah OJ, Iniguez-Lluhi JA, Romanelli A, Kimball SR, Jefferson LS. The activated glucocorticoid receptor modulates presumptive autoregulation of ribosomal protein S6 protein kinase, p70 S6K. The Journal of Biological Chemistry. 277: 2525-33. PMID 11705993 DOI: 10.1074/Jbc.M105935200 |
0.322 |
|
| Show low-probability matches. |